Ohio RETAIN Impact Evaluation

Status Recruiting

Clinical Trial Summary

The Retaining Employment and Talent after Injury/Illness Network (RETAIN) demonstration is a collaborative effort between the U.S. Department of Labor (DOL) and the Social Security Administration (SSA) to improve employment outcomes for individuals who experience injuries or illnesses that put them at risk of exiting the labor force and relying on disability programs and other public supports in the long term. RETAIN projects include a combination of medical provider services, stay-at-work/return-to-work (SAW/RTW) coordination services, and other SAW/RTW services. This evaluation will focus on the Ohio Department of Job and Family Services' implementation of "Ohio RETAIN." The evaluation will document how the project is implemented, describe enrollees, estimate the project's impacts on enrollees' outcomes, and assess whether the benefits outweigh the costs.

Clinical Trial Description

The Ohio Department of Job and Family Services has partnered with Mercy Health to implement "Ohio RETAIN" in Youngstown, Toledo and Cicinnati catchment areas. SSA contracted with Mathematica to conduct an independent evaluation of the program. Under the RETAIN model medical providers receive training and incentives to use occupational health best practices. The state agency also coordinates SAW/RTW services for the enrollee, fosters communication among Ohio RETAIN stakeholders about the treatment enrollee returning to work, and monitors the enrollee's medical and employment progress. The Business Resource Network and OhioMeansJobs provide additional support for workplace-based interventions and retaining or rehabilitation of enrollees. Ohio recruits potentially eligible workers as they receive care from medical providers. The evaluation team randomly assigns each enrollee to either a treatment group that is eligible to receive the full set of RETAIN intervention activities or a control group that is not. The evaluation team then compares the outcomes of the treatment and control groups and gathers evidence on how Ohio RETAIN shaped the outcomes of enrollees who were eligible for its services, regardless of whether they participated in those services. Data sources include enrollment data, surveys, administrative records, program data, and qualitative data. ;

Study Design

Related Conditions & MeSH terms

Disability

Clinical Trial Details

NCT number	NCT05219045
Study type	Interventional
Source	Mathematica Policy Research, Inc.
Contact	Amaka Osuoha, MPH
Phone	734-205-3085
Email	aosuoha@mathematica-mpr.com
Status	Recruiting
Phase	N/A
Start date	January 19, 2022
Completion date	February 2028

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00906152` - Association Between Low Back Pain and Quality of Sleep	N/A
Completed	`NCT00907049` - Association Between Neck Pain and Quality of Sleep	N/A
Recruiting	`NCT05394363` - Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Recruiting	`NCT05167981` - RETAINWORKS Impact Evaluation	N/A
Completed	`NCT01736644` - Bipolar Sealer Aquamantys Use in Total Knee Replacement	N/A
Completed	`NCT01407913` - Caudal Epidural Steroid Injections for Low Back Pain/Sciatic Lumbar Pain	Phase 4
Enrolling by invitation	`NCT05173350` - RETAIN Kentucky Impact Evaluation	N/A
Completed	`NCT04571827` - The Influence of Expectations on Post-needling Soreness and Pain Processing After Dry Needling Treatment	N/A
Recruiting	`NCT03898362` - Pneumatic Technology for Powered Mobility Devices	N/A
Completed	`NCT02192658` - Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa	N/A
Completed	`NCT01600547` - Odense Fallers and Osteoporosis Study	N/A
Completed	`NCT00526994` - Randomized Controlled Trial of Routine Screening for IPV	Phase 2/Phase 3
Completed	`NCT00278096` - Randomised Controlled Trial of Unsolicited Occupational Therapy in Community-Dwelling Elderly	N/A
Not yet recruiting	`NCT06190041` - Kinesiophobia in Patients With Chronic Low Back Pain
Recruiting	`NCT05611723` - Study and Analysis of Biomechanical Parameters of Human Movement Based on Disability Indicators in Older Adults
Recruiting	`NCT05656690` - Prospective Study and Analysis of Biomechanical Parameters of Human Movement Based on Disability Indicators in Older Adults
Recruiting	`NCT05821140` - Orofacial Functions and Masticatory Function in Children With Different Types of Deterioration in Oral Health	N/A
Completed	`NCT02263716` - Actigraphy to MEasuRe Intensive Care Unit Activity	N/A
Recruiting	`NCT03408522` - Troponin Elevation After Major Noncardiac Surgery 2
Completed	`NCT01241071` - Effects of Myofascial Release on Pain, Disability and Electromyography of Erector Spinae in Chronic Low Back Pain	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.